Prognostic significance and molecular associations of 18q loss of heterozygosity: A cohort study of microsatellite stable colorectal cancers

Journal of Clinical Oncology

Volumn 27, Issue 27, 2009, Pages 4591-4598

  Ogino, Shuji ^a   Nosho, Katsuhiko ^a   Irahara, Natsumi ^a   Shima, Kaori ^a   Baba, Yoshifumi ^a   Kirkner, Gregory J ^a   Meyerhardt, Jeffrey A ^a   Fuchs, Charles S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; BETA CATENIN; K RAS PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P53; VIRUS T ANTIGEN;

AGED; ARTICLE; BODY MASS; CANCER GRADING; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 18Q; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; JC VIRUS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS;

AGED; CHROMOSOMES, HUMAN, PAIR 18; COHORT STUDIES; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; FEMALE; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; SURVIVAL ANALYSIS;

EID: 76749132120     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.22.8858     Document Type: Article

References (49)

1. Grady WM, Carethers JM: Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 135:1079-1099, 2008
2. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61:759-767, 1990
3. Thiagalingam S, Lengauer C, Leach FS, et al: Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 13:343-346, 1996
4. Park do Y, Sakamoto H, Kirley SD, et al: The Cables gene on chromosome 18q is silenced by promoter hypermethylation and allelic loss in human colorectal cancer. Am J Pathol 171:1509-1519, 2007
5. Watanabe T, Wu TT, Catalano PJ, et al: Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 344:1196-1206, 2001
6. Jass JR: Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50:113-130, 2007
7. Ogino S, Goel A: Molecular classification and correlates in colorectal cancer. J Mol Diagn 10:13-27, 2008
8. Jen J, Kim H, Piantadosi S, et al: Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 331:213-221, 1994
9. Ogunbiyi OA, Goodfellow PJ, Herfarth K, et al: Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator. J Clin Oncol 16:427-433, 1998
10. Zhou W, Goodman SN, Galizia G, et al: Counting alleles to predict recurrence of early-stage colorectal cancers. Lancet 359:219-225, 2002
11. Diep CB, Thorstensen L, Meling GI, et al: Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients. J Clin Oncol 21:820-829, 2003
12. Carethers JM, Hawn MT, Greenson JK, et al: Prognostic significance of allelic lost at chromosome 18q21 for stage II colorectal cancer. Gastroenterology 114:1188-1195, 1998
13. Halling KC, French AJ, McDonnell SK, et al: Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst 91:1295-1303, 1999
14. Barratt PL, Seymour MT, Stenning SP, et al: DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: A molecular study. Lancet 360:1381-1391, 2002
15. Roth A, Tejpar S, Yan P, et al: State-specific prognostic value of molecular markers in colon cancer: Results of the translational study on the PETACC 3 - EORTC 40993-SAKK 60-00 trial. J Clin Oncol 27:15s, 2009 (suppl; abstr 4002)
16. Jernvall P, Makinen MJ, Karttunen TJ, et al: Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers. Br J Cancer 79:903-908, 1999
17. Popat S, Hubner R, Houlston RS: Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 23:609-618, 2005
18. Popat S, Houlston RS: A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis. Eur J Cancer 41:2060-2070, 2005
19. Colditz GA, Hankinson SE: The Nurses' Health Study: Lifestyle and health among women. Nat Rev Cancer 5:388-396, 2005
20. Chan AT, Ogino S, Fuchs CS: Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med 356:2131-2142, 2007
21. Ogino S, Kawasaki T, Brahmandam M, et al: Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. J Mol Diagn 7:413-421, 2005
22. Ogino S, Kawasaki T, Kirkner GJ, et al: CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: Possible associations with male sex and KRAS mutations. J Mol Diagn 8:582-588, 2006
23. Nosho K, Kawasaki T, Ohnishi M, et al: PIK3CA mutation in colorectal cancer: Relationship with genetic and epigenetic alterations. Neoplasia 10:534-541, 2008
24. Ogino S, Brahmandam M, Cantor M, et al: Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component. Mod Pathol 19:59-68, 2006
25. Ogino S, kawasaki T, Brahmandam M, et al: Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn 8:209-217, 2006
26. Ogino S, Cantor M, Kawasaki T, et al: CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut 55:1000-1006, 2006
27. Ogino S, Kawasaki T, Kirkner GJ, et al: Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. J Mol Diagn 9:305-314, 2007
28. Weisenberger DJ, Siegmund KD, Campan M, et al: CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38:787-793, 2006
29. Ogino S, Kawasaki T, Nosho K, et al: LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG methylator phenotype in colorectal cancer. Int J Cancer 122:2767-2773, 2008
30. Ogino S, Brahmandam M, kawasaki T, et al: Combined analysis of COX-2 and p53 expressions reveals synergistic inverse correlations with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Neoplasia 8:458-464, 2006
31. Nosho K, Shima K, Kure S, et al: JC virus T-antigen in colorectal cancer is associated with p53 expression and chromosomal instability, independent of CpG island methylator phenotype. Neoplasia 11:87-95, 2009
32. Ogino S, Kawasaki T, Kirkner GJ, et al: Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP. Mod Pathol 20:15-22, 2007
33. Kawasaki T, Nosho K, Ohnishi M, et al: Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer. Neoplasia 9:569-577, 2007
34. Durrleman S, Simon R: Flexible regression models with cubic splines. Stat Med 8:551-561, 1989
35. Ogino S, Nosho K, Meyerhardt JA, et al: Cohort study of fatty acid synthase expression and patient survival in colon cancer. J Clin Oncol 26: 5713-5720, 2008
36. Ogino S, Nosho K, Kirkner GJ, et al: CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut 58:90-96, 2009
37. Ogino S, Nosho K, Kirkner GJ, et al: A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J Natl Cancer Inst 100:1734-1738, 2008
38. Ogino S, Nosho K, Kirkner GJ, et al: PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer. J Clin Oncol 27:1477-1484, 2009
39. Braun MS, Richman SD, Quirke P, et al: Predictive biomarkers of chemotherapy efficacy in colorectal cancer: Results from the UK MRC FOCUS trial. J Clin Oncol 26:2690-2698, 2008
40. Cohen SJ, Punt CJ, Iannotti N, et al: Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 26:3213-3221, 2008
41. Di Nicolantonio F, Martini M, Molinari F, et al: Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer. J Clin Oncol 26:5705-5712, 2008
42. Mitry E, Fields AL, Bleiberg H, et al: Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: A pooled analysis of two randomized trials. J Clin Oncol 26:4906-4911, 2008
43. Weiser MR, Landmann RG, Kattan MW, et al: Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol 26:380-385, 2008
44. Martínez-López E, Abad A, Font A, et al: Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer. Gastroenterology 114: 1180-1187, 1998
45. Sarli L, Bottarelli L, Bader G, et al: Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q. Dis Colon Rectum 47:1467-1482, 2004
46. Matsuzaki K, Deng G, Tanaka H, et al: The relationship between global methylation level, loss of heterozygosity, and microsatellite instability in sporadic colorectal cancer. Clin Cancer Res 11:8564-8569, 2005
47. Suzuki K, Suzuki I, Leodolter A, et al: Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 9:199-207, 2006
48. Rodriguez J, Frigola J, Vendrell E, et al: Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers. Cancer Res 66:8462-9468, 2006
49. Ricciardiello L, Baglioni M, Giovannini C, et al: Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus. Cancer Res 63:7256-7262, 2003